Structural and Functional Characterization of Rare Ocular Diseases

Launched by BARCELONA MACULA FOUNDATION · Feb 17, 2022

Keywords

ClinConnect Summary

This clinical trial is studying rare eye diseases that affect vision, specifically focusing on conditions like Retinitis Pigmentosa, Stargardt Disease, and others. These diseases typically don't have available treatments and can lead to progressive vision loss. The goal of the study is to better understand how these conditions develop and change over time, which can help in future research and treatment options.

To participate in this trial, individuals must be 18 years or older with a confirmed diagnosis of one of the rare eye diseases affecting the back part of the eye. Participants should be able to complete several eye exams and must agree to sign a consent form. However, those with other eye disorders, certain medical conditions, or who have had recent eye surgeries might not be eligible. If you join, you will undergo a series of eye tests to help researchers gather important information about these diseases. The study is currently recruiting participants, and everyone, regardless of gender, is welcome to apply.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Male or female 18 years or older with a diagnosis of a ROD affecting the posterior segment
• • Patients able to undergo all required ophthalmic exams
• • Patients able and willing to sign an informed consent
• Exclusion Criteria:
• • Patients with other concomitant posterior segment disorders
• • Patients taking drugs known to affect the retina and/or optic nerve
• • Patients that underwent an intraocular surgery (aside from phacoemulsification with intraocular lens implantation), corneal or glaucoma surgery
• • Patients who have participated in the past 12 months or that are currently participating in clinical trials for an ocular disease